QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in around one hour.

The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the FDA with priority review.

Researchers in Spain are working to develop faster, more accurate methods for detecting viruses like human norovirus and hepatitis A in fresh produce. The

Barcelona-based Sycai Medical has closed a €3M funding round backed by LUMO Labs, Ship2B Ventures, Athos Capital, and Namarel Ventures.

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Bengaluru-based cell and gene therapy start-up Immuneel Therapeutics on Monday announced the launch of Qartemi -- the countr

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the country’s first global CAR T-cell therapy, that uses genetically modified T cells to fight the terminal disease.

Immuneel Therapeutics launches affordable CAR-T therapy Qartemi for B-cell Non-Hodgkin Lymphoma, aiming to revolutionize cancer treatment in India.

Football legends Michael Vick and Michael Strahan are set to enter the College Football Hall of Fame.

There has been tremendous interest in cell-based meat, not least for its touted long-term potential to aid world food security.

Carlo Ancelotti says his Real Madrid side are still hurting from their 5-2 Super Cup defeat against Barcelona.

Real Madrid came out looking for some payback in the latest “clasico” against Barcelona but ended up being embarrassed again. Madrid lost 5-2 to Barcelona in the Spanish Super Cup